DRUG

#2303
Bright Minds Biosciences Inc. - common stock
88.0 7 USD
-1.82%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
88.07
88.07
Jahresspanne
23.18
123.75
Tagesänderung
-1.82%
Monatliche Änderung
-1.01%
6 month change
+26.27%
Jahresänderung
+224.98%
Vorheriger Schlusskurs
89.7 0
Open
88.0 7
Tief
88.0 7
High
88.0 7
Volumen
24
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert 20212022202320242025 TTM

Bright Minds Biosciences Inc. - common stock

Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use. It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens. The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York.

Nachrichten